ArticleFrontiers in oncology2022

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer.

Zihua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.